Recently, IRF-1 was reported to be a positive prognostic factor in ovarian and colorectal cancer (Galon et al, 2006; Zeimet et al, 2009) and was found to be associated with infiltration of CD8+ T lymphocytes in ovarian cancer (Callahan et al, 2008). The gene discussed is IRF1; the disease is ovarian cancer.